 or in
adjusted outcomes. However, the authors of this report
noted that the study was limited by failure to capture
the costs of managing strokes in the study, and the fact
that the costs of supplies may not apply to other
countries.673
Although the clinical results of CAS continue to
improve, it seems clear from objective evidence accumulated to date that more broad-based applicability may
be limited by economic considerations. This should be
considered by clinicians when